A new clinical trial has been introduced to treat an aggressive form of breast cancer. The trial is taking place here in Columbus, Ohio at The Ohio State University Wexner Medical Center. It will involve targeted treatment of an aggressive form of breast cancer and it could revolutionize the way breast cancer is treated.
“This could really revolutionize the way women are treated with breast cancer,” said Dr. Erin Macrae, of the OSU Comprehensive Breast Center.
Chemotherapy is currenly the only option for treating patients with triple negative breast cancer. Chemotherapy produces numerous side effects including hair loss. The medicine in the clinical trial is less toxic and will allow breast cancer patients to lead more of a normal lifestyle.
The Wexner Medical Center is the first in the nation to introduce this new treatment which will begin soon. Doctors are looking for women with advanced triple negative breast cancer to participate. Anyone interested can call 614-293-5066.